Subscribe To
Gbp/usd loses the 1.22 handle to close out friday trading
The GBP/USD is currently pinned to the midpoint at the 34-hour Exponential Moving Average (EMA) as intraday momentum ...
September 29, 2023, 9:59 pm
Motus gi completes first clinical evaluation of new pure-vu® gastro in upper gastrointestinal (gi) procedures to support fda submission
– Pure-Vu Gastro achieves high usability scores in supporting upper endoscopy procedures with first time users – – On track to submit a 510(k) t...
May 17, 2023, 12:30 pm
Fraport: a growth story that bleeds cash
Fraport faces significant cash outflows as it fuels big construction projects that will pay off in several years. Dividend likely to remain suspended ...
March 21, 2023, 4:11 pm
Anavex: drug treatments for early alzheimer's disease
Anavex 2-73/blarcamesine at high concentrations in early Alzheimer's disease leads to improvements in cognition and activities of daily living that ar...
January 17, 2023, 5:10 pm
Dalal street bleeds: equities tumble nearly 2 pc; sensex settles below 60k
The 30-share BSE Sensex continued to remain under selling pressure for the fourth day running and slumped 980.93 points or 1.61 per cent to settle at ...
December 23, 2022, 11:14 am
Bed bath & beyond bleeds cash, seeks buybuy baby buyer
Two days after replacing its CEO amid plummeting sales, Bed Bath & Beyond is seeking a buyer for its Buybuy Baby business. As the Wall Street Journal ...
July 1, 2022, 5:14 pm
Netflix's ceo says he's open to creating a lower-priced tier with ads as the company bleeds subscribers
The major reversal came as Netflix said it lost 200,000 subscribers in its first quarter — the streaming service's first decline since 2011....
April 19, 2022, 11:48 pm
Netflix stock slides 18% as service bleeds 200,000 subscribers
Global streaming giant Netflix on Tuesday reported losing subscribers for the first time in more than a decade and predicted more contraction in the s...
April 19, 2022, 5:28 pm
Astrazeneca's ondexxya wins approval for reversal of acute major bleeds in patients
AstraZeneca PLC (LSE:AZN) said its Ondexxya treatment was approved in Japan, the first approved reversal agent specifically for Factor Xa inhibitors ...
March 29, 2022, 5:31 am
Sanofi's (sny) hemophilia a candidate meets study endpoints
Sanofi (SNY) and Sobi's factor VIII replacement therapy candidate, efanesoctocog alfa, achieves clinically meaningful prevention of ...
March 10, 2022, 12:02 pm